In 2022, total Medicare expenditures on the GLP-1/GIP agonists were $5.7 billion
People who do not meet the above conditions still use semaglutide for weight loss
Combination therapy with a GLP-1 RA and a SGLT2i has been reported to involve additional benefits in the management of T2DM compared with monotherapy through different mechanisms (11)
In the 1 mg trial arm, liver fat fell 51% among participants with fatty liver, visceral fat fell 16%, and triglycerides declined. Ketones are a separate matter: the same substudy found -hydroxybutyrate rose only at 4 mg and above, so the 1 mg arm does not carry a ketone signal in that population. Modeled metabolic-health protocols place heavier, metabolically average profiles near 1 mg weekly
Vitality Weight Loss is a physician-led clinic at 6140 Brent Thurman Way, Suite 100 in Las Vegas, offering semaglutide, tirzepatide, and oral GLP-1, all medically reviewed by Peter DeBry, MD